Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Senseonics Holdings Inc SENS

Healthcare Medical Devices
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The... see more

Recent & Breaking News (NYSEAM:SENS)

Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem

Business Wire August 3, 2022

Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time

Business Wire July 26, 2022

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire July 5, 2022

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

Business Wire June 16, 2022

Senseonics to Participate in the Jefferies Healthcare Conference

Business Wire May 26, 2022

Senseonics to Participate in the H.C. Wainwright Global Investment Conference

Business Wire May 16, 2022

Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results

Business Wire May 10, 2022

Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time

Business Wire April 26, 2022

Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.

Business Wire April 6, 2022

Senseonics Announces Equity Grants to Employees Under Inducement Plan

Business Wire April 1, 2022

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

Business Wire March 1, 2022

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern Time

Business Wire February 15, 2022

ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS

PR Newswire February 14, 2022

Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook

Business Wire February 11, 2022

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire January 5, 2022

Senseonics Announces Business Updates

Business Wire January 4, 2022

Senseonics Holdings, Inc. Reports Third Quarter 2021 Financial Results

Business Wire November 9, 2021

Senseonics to Participate in Upcoming November Investor Conferences

Business Wire November 8, 2021

Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time

Business Wire October 26, 2021

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire October 4, 2021